KMTS

Profile

Full Name

Kestra Medical Technologies, Ltd. Common Stock

Ticker Symbol

KMTS

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Instruments & Supplies

Country

United States

IPO

March 6, 2025

Indexes

Not included

Website

http://kestramedical.com

Employees

300

Key Details

Price

$24.50(-0.33%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$27.49M(+189.91% YoY)

Annual EPS

-$0.96(+13.50% YoY)

PE ratio

-

Next earnings date

May 15, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$24.50
KMTS price is $24.50

30-Day Relative Volume

0.51
KMTS 30-day relative volume is 0.51

Price Performance

Price Most recent change

-0.33%
KMTS price was down -0.33% on Apr 17, 2025

Price YTD change

-
KMTS price ytd change is unknown

Price 1-year change

-
KMTS price 1-year change is unknown

Price 3-year change

-
KMTS price 3-year change is unknown

Price Range

Price All-time high

$26.15
KMTS price is currently -6.31% below its historical high of $26.15

Price 3-year low

$20.00
KMTS price is currently +22.50% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$1.17B
KMTS market capitalization is $1.17 billion

Market cap 3-year change

-
KMTS market capitalization 3-year change is unknown

Market cap All-time high

$1.22B
KMTS market capitalization is currently -4.67% below its historical high of $1.22 billion

Market cap sector rank

-
KMTS market capitalization is unknown

Shares Outstanding

Shares Outstanding 1-Year Change

-
KMTS shares outstanding 1-year change is unknown

Shares Outstanding 3-Year Change

-
KMTS shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.84
KMTS beta is 0.84

200-day SMA

$23.39
KMTS price is currently +4.74% above its 200-day simple moving average

50-day SMA

$23.39
KMTS price is currently +4.74% above its 50-day simple moving average

RSI

55.35
KMTS 14-day relative strength index is 55.35

Volume

0.51
KMTS 30-day relative volume is 0.51

ATR

$2.02
KMTS average true range is $2.02

10-day Historical Volatility

60.61%
KMTS 10-day historical volatility is 60.61%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$27.49M
KMTS annual revenue is $27.49 million

Revenue Analysts estimate

$58.25M
KMTS annual revenue is currently -52.81% lower than the consensus analysts' forecast

Revenue 1-year change

+189.91%
KMTS annual revenue is up +189.91% year-on-year

Revenue Sector rank

-
KMTS annual revenue is unknown

EPS

EPS

-$0.96
KMTS annual earnings per share is -$0.96

EPS Analysts estimate

-$2.20
KMTS annual earnings per share is currently -56.20% lower than the consensus analysts' forecast

EPS 1-year change

+13.5%
KMTS annual earnings per share is up +13.5% year-on-year

EPS Sector rank

-
KMTS annual earnings per share is unknown

Profit

Gross profit

$10.03M
KMTS annual gross profit is $10.03 million

Gross margin

36.48%
KMTS annual gross profit margin is 36.48%

Operating profit

-$37.56M
KMTS annual operating income is -$37.56 million

Operating margin

-136.64%
KMTS annual operating profit margin is -136.64%

Net income

-$40.25M
KMTS annual net profit is -$40.25 million

Net margin

-146.41%
KMTS annual net profit margin is -146.41%

Expenses

Total expenses

$65.06M
KMTS annual total expenses is $65.06 million

Operating expenses

$47.59M
KMTS annual total operating expenses is $47.59 million

Cost of goods sold

$17.46M
KMTS annual cost of goods sold is $17.46 million

Selling, general & administrative expenses

$40.68M
KMTS annual SGA is $40.68 million

Depreciation and amortization

$11.56M
KMTS annual depreciation & amortization is $11.56 million

Interest expense

$3.28M
KMTS annual interest expense is $3.28 million

Income tax

$15.00K
KMTS annual income tax is $15.00 thousand

EBIT & EBITDA

EBIT

-$37.65M
KMTS annual earnings before interest & taxes is -$37.65 million

EBITDA

-$26.09M
KMTS annual EBITDA is -$26.09 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$45.95M
KMTS annual total assets is $45.95 million

Non current assets

$31.04M
KMTS annual long term assets is $31.04 million

Current assets

$14.91M
KMTS annual total current assets is $14.91 million

Cash and cash equivalents

$8.25M
KMTS annual cash & cash equivalents is $8.25 million

Accounts receivable

$2.00M
KMTS annual accounts receivable is $2.00 million

Inventory

$3.29M
KMTS annual inventory is $3.29 million

Liabilities

Total liabilities

$255.33M
KMTS annual total liabilities is $255.33 million

Long term liabilities

$222.35M
KMTS annual total long term liabilities is $222.35 million

Current liabilities

$32.97M
KMTS annual total current liabilities is $32.97 million

Accounts payable

$23.89M
KMTS annual accounts payable is $23.89 million

Debt

Total debt

$45.17M
KMTS annual total debt is $45.17 million

Total debt 1-year change

+15.42%
KMTS annual total debt is up +15.42% year-on-year

Long term debt

$45.17M
KMTS annual long term debt is $45.17 million

Short term debt

$0.00
KMTS annual short term debt is $0.00

Equity & Capital

Shareholders equity

-$209.38M
KMTS annual stockholders equity is -$209.38 million

Book value

-$209.38M
KMTS annual book value is -$209.38 million

Retained earnings

-$406.44M
KMTS annual retained earnings is -$406.44 million

Working capital

-$18.06M
KMTS annual working capital is -$18.06 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$72.23M
KMTS annual cash flow from operations is -$72.23 million

Cash from operations 1-year change

-3.72%
KMTS annual cash flow from operations is down -3.72% year-on-year

Cash from investing

-$12.23M
KMTS annual cash flow from investing activities is -$12.23 million

Cash from investing 1-year change

+20.9%
KMTS annual cash flow from investing activities is up +20.9% year-on-year

Cash from financing

$77.72M
KMTS annual cash flow from financing activities is $77.72 million

Cash from financing 1-year change

-19.13%
KMTS annual cash flow from financing activities is down -19.13% year-on-year

CAPEX

CAPEX

$12.51M
KMTS annual capital expenditures is $12.51 million

CAPEX 1-year change

-19.06%
KMTS annual capital expenditures is down -19.06% year-on-year

Free Cash Flow

Free cash flow

-$84.75M
KMTS annual free cash flow is -$84.75 million

Free cash flow 1-year change

+0.42%
KMTS annual free cash flow is up +0.42% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

36.48%
KMTS annual gross profit margin is 36.48%

Operating margin

-136.64%
KMTS annual operating profit margin is -136.64%

Net margin

-146.41%
KMTS annual net profit margin is -146.41%

ROA & ROE

ROA

-95.15%
KMTS annual return on assets is -95.15%

ROE

19.22%
KMTS annual return on equity is 19.22%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
KMTS price to earnings ratio value is unknown

PE ratio Sector rank

-
KMTS price to earnings ratio is unknown

PB Ratio

PB ratio

-4.62
KMTS price to book ratio is -4.62

PB ratio Sector rank

-
KMTS price to book ratio is unknown

PS Ratio

PS ratio

-
KMTS price to sales ratio value is unknown

PS ratio Sector rank

-
KMTS price to sales ratio is unknown

Enterprise value

Enterprise value

$1.14B
KMTS enterprise value is $1.14 billion

Enterprise value Sector rank

-
KMTS enterprise value is unknown

EV/EBITDA

EV/EBITDA

-
KMTS EV/EBITDA value is unknown

EV/EBITDA Sector rank

-
KMTS EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.45
KMTS annual current ratio is 0.45

Quick ratio

0.35
KMTS annual quick ratio is 0.35

Leverage

Debt to equity

-0.20
KMTS annual debt to equity ratio is -0.20

Interest coverage ratio

-11.49
KMTS annual interest coverage ratio is -11.49

Risk & Stability

Piotroski F-Score

-
KMTS piotroski f-score value is unknown

Altman Z-Score

-12.22
KMTS altman z-score is -12.22

Analyst ratings

Recent major analysts updates

Apr 16, 25 Goldman Sachs
Neutral
Mar 31, 25 Wolfe Research
Outperform
Mar 31, 25 Wells Fargo
Overweight
Mar 31, 25 Stifel
Buy
Mar 31, 25 Piper Sandler
Overweight
Mar 31, 25 Goldman Sachs
Neutral

Institutional Ownership

Similar stocks

LQDA logo
Liquidia (LQDA)
OCUL logo
Ocular Therapeutix (OCUL)
AZTA logo
Azenta (AZTA)
ARDX logo
Ardelyx (ARDX)
INVA logo
Innoviva (INVA)
PLSE logo
Pulse Biosciences (PLSE)
PCRX logo
Pacira BioSciences (PCRX)
TDOC logo
Teladoc Health (TDOC)
Indivior (INDV)
  • What is the ticker symbol for Kestra Medical Technologies?
  • Does Kestra Medical Technologies pay dividends?
  • What sector is Kestra Medical Technologies in?
  • What industry is Kestra Medical Technologies in?
  • What country is Kestra Medical Technologies based in?
  • When did Kestra Medical Technologies go public?
  • Is Kestra Medical Technologies in the S&P 500?
  • Is Kestra Medical Technologies in the NASDAQ 100?
  • Is Kestra Medical Technologies in the Dow Jones?
  • When was Kestra Medical Technologies's last earnings report?
  • When does Kestra Medical Technologies report earnings?
  • Should I buy Kestra Medical Technologies stock now?

What is the ticker symbol for Kestra Medical Technologies?

The ticker symbol for Kestra Medical Technologies is NASDAQ:KMTS

Does Kestra Medical Technologies pay dividends?

No, Kestra Medical Technologies does not pay dividends

What sector is Kestra Medical Technologies in?

Kestra Medical Technologies is in the Healthcare sector

What industry is Kestra Medical Technologies in?

Kestra Medical Technologies is in the Medical Instruments & Supplies industry

What country is Kestra Medical Technologies based in?

Kestra Medical Technologies is headquartered in United States

When did Kestra Medical Technologies go public?

Kestra Medical Technologies's initial public offering (IPO) was on March 6, 2025

Is Kestra Medical Technologies in the S&P 500?

No, Kestra Medical Technologies is not included in the S&P 500 index

Is Kestra Medical Technologies in the NASDAQ 100?

No, Kestra Medical Technologies is not included in the NASDAQ 100 index

Is Kestra Medical Technologies in the Dow Jones?

No, Kestra Medical Technologies is not included in the Dow Jones index

When was Kestra Medical Technologies's last earnings report?

Kestra Medical Technologies's most recent earnings report was on Apr 14, 2025

When does Kestra Medical Technologies report earnings?

The next expected earnings date for Kestra Medical Technologies is May 15, 2025

Should I buy Kestra Medical Technologies stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page